Lyon Joseph Douglas, Chief Accounting&Technology Officer exercised 7,404 shares of CORCEPT THERAPEUTICS INC ($CORT) @ $13.56 ($100,398.24 total) on Sep 14, 2026

Lyon Joseph Douglas – Chief Accounting&Technology Officer

Sep 14, 2026

52W Low$28.66

Current$111.8185.1% above low, 14.9% below high

Purchase$13.56-15.5% above low, 115.5% below high

52W High$126.38

7,404

Price

$13.56

Total Value

$100,398.24

Nearby Earnings

No earnings within 2 weeks of this transaction.

Insider	Lyon Joseph Douglas
Title	Chief Accounting&Technology Officer
Transaction Date	Sep 14, 2026
Transaction Code	M Exercise/Conversion
Acquired/Disposed	Acquired
Security	Common Stock
Direct/Indirect	Direct
Filing Date	Sep 16, 2026
Shares Purchased	7,404
Price per Share	$13.56
Total Value	$100,398.24
Shares Owned After	15,683
Derivative	No
Accession Number	0001193125-26-393125
Document	View SEC Filing